Glen Mills, PA, United States of America

William Dickheiser

This inventor holds 1 USPTO granted patent. Top assignee: Softkemo Pharma Corp.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Dickheiser. Retrieved from https://idiyas.com/inventor/william-dickheiser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: William Dickheiser: Inventor of a Lyophilized Bendamustine-Cyclodextrin Composition

Introduction

William Dickheiser is an inventor associated with Glen Mills, Pennsylvania, and Softkemo Pharma Corp. His patent work concerns a formulation of bendamustine, a cancer-treatment drug, designed to support storage stability and convenient preparation for administration.

Latest Patents

Dickheiser is associated with 1 patent, titled “Lyophilized Bendamustine-Cyclodextrin Composition.” The patent describes a freeze-dried composition containing bendamustine and sulfobutylether beta-cyclodextrin (SBECD) in a molar excess relative to bendamustine. The composition contains no mannitol and has a water content of less than about 1% by weight.

The formulation may form a well-shaped cake and is described as having desirable storage stability. It can be quickly reconstituted for administration to cancer patients, including patients who need to reduce their sodium and/or sugar intake. The patent also describes methods for preparing the composition and using it in cancer treatment.

Career Highlights

Dickheiser’s listed patent reflects work on pharmaceutical formulation and drug delivery. Its focus is on the composition’s physical properties, storage characteristics, and preparation for clinical administration.

Collaborations

Dickheiser is associated with Softkemo Pharma Corp. His listed coworker is Kishore Patel.

Conclusion

William Dickheiser’s patent centers on a lyophilized bendamustine formulation intended to combine storage stability with rapid reconstitution, highlighting his contribution to pharmaceutical innovation for cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…